Back

Prognostic value of heart failure hospitalization in transthyretin cardiac amyloidosis: an international cohort study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Predicting outcomes in cardiac amyloidosis Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Dorien Laenens

AZ Sint Maarten, Mechelen (Belgium)

6 More presentations in this session

Presentation thumbnail
Aortic calcium scoring from computed tomography for signal localization by bone scintigraphy to predict aortic stenosis and assess prognosis in patients with transthyretin cardiac amyloidosis
Mr B. Guillaume (Toulouse, FR)
Abstract Slides Video
Presentation thumbnail
Sex-based differences in phenotypic expression and prognosis of transthyretin cardiac amyloidosis associated with the Val122Ile variant
Doctor A. Monfort (Fort-de-France, MQ)
Abstract Slides Video
Presentation thumbnail
The incidence of death and risk factors for mortality in cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records
Doctor L. Anderson (London, GB)
Abstract Slides Video
Presentation thumbnail
Myocardial stiffness and mortality risk in cardiac amyloidosis: a shear wave elastography analysis
Doctor C. Espinoza Romero (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Incidence of death and thromboembolic events in patients with light chains and transthyretin cardiac amyloidosis: data from an institutional registry
Miss P. Domenech (Buenos Aires, AR)
Abstract Slides Video

Access the full session

Session thumbnail
Predicting outcomes in cardiac amyloidosis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Prognostic factors associated with survival in patients with wild-type transthyretin amyloid cardiomyopathy, treated with tafamidis
thumbnail
Congress Presentation
Evolving disease characteristics in cardiac amyloidosis: real-world data from a tertiary referral center
thumbnail
Congress Presentation
T-Amylo score for the diagnosis of transthyretin cardiac amyloidosis in patients with acute heart failure.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources